-
15075-25An inhibitor of SRE activation in PC3 cells (IC<sub>50</sub> = 6.4 &muM), with 87% inhibition of SRE activation achieved at 100 &muM inhibits PC3 cell migration (IC<sub>50</sub> = 4.
-
15075-5An inhibitor of SRE activation in PC3 cells (IC<sub>50</sub> = 6.4 &muM), with 87% inhibition of SRE activation achieved at 100 &muM inhibits PC3 cell migration (IC<sub>50</sub> = 4.
-
15075-50An inhibitor of SRE activation in PC3 cells (IC<sub>50</sub> = 6.4 &muM), with 87% inhibition of SRE activation achieved at 100 &muM inhibits PC3 cell migration (IC<sub>50</sub> = 4.
-
10802-1An inhibitor of RGS4 (IC50 = 30 nM) blocks GTPase activity and G&alpha0-dependent translocation of RGS4 to the membrane.
-
10802-10An inhibitor of RGS4 (IC50 = 30 nM) blocks GTPase activity and G&alpha0-dependent translocation of RGS4 to the membrane.
-
10802-5An inhibitor of RGS4 (IC50 = 30 nM) blocks GTPase activity and G&alpha0-dependent translocation of RGS4 to the membrane.
-
10012591-1A 3,4-diaryl pyrazoloresorcinol compound that inhibits the Hsp90 ATPase activity with IC50 values of 3.2 and 6.
-
10012591-10A 3,4-diaryl pyrazoloresorcinol compound that inhibits the Hsp90 ATPase activity with IC50 values of 3.2 and 6.
-
10012591-5A 3,4-diaryl pyrazoloresorcinol compound that inhibits the Hsp90 ATPase activity with IC50 values of 3.2 and 6.
-
18194-1An ATP-competitive inhibitor of Akt2 (IC<sub>50</sub> = 6 nM) blocks the phosphorylation of Akt targets, inhibits proliferation of multiple tumor cell lines in vitro, and prevents the growth of human tumor xenografts in mice.
-
18194-10An ATP-competitive inhibitor of Akt2 (IC<sub>50</sub> = 6 nM) blocks the phosphorylation of Akt targets, inhibits proliferation of multiple tumor cell lines in vitro, and prevents the growth of human tumor xenografts in mice.
-
18194-5An ATP-competitive inhibitor of Akt2 (IC<sub>50</sub> = 6 nM) blocks the phosphorylation of Akt targets, inhibits proliferation of multiple tumor cell lines in vitro, and prevents the growth of human tumor xenografts in mice.